Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Synergy Resources Corp (SYRG) Disappoints In Fiscal Q3 But Hedge Funds Are Betting On The Stock

Page 1 of 2

Synergy Resources Corp (NYSEMKT:SYRG) posted disappointing results for its fiscal third quarter today, reporting a loss of $2.5 million, or $0.20 per basic and diluted share, down from net income of $7.2 million, or $0.09 per basic and diluted share, in the third fiscal quarter of 2014. The loss for the quarter ending May 31 includes a $3 million full cost ceiling impairment charge resulting from lower oil and gas prices, the firm noted. The Street was expecting earnings of $0.01 per share. The oil and gas exploration and production firm says that revenues for the third quarter increased by 1.4% to $26.0 million from $25.7 million in the same quarter last year. The growth comes from a 95% increase in production, primarily from the new horizontal wells brought online, and production from acquisitions and asset swaps with other operators, the firm said. This growth was offset, however, by a 48% decrease in the realized average selling price per barrel of oil equivalent, the energy company added.

Synergy Resources Corp (SYRG), NYSEMKT:SYRG,

The disappointing results for Synergy Resources Corp (NYSEMKT:SYRG)’s fiscal third quarter, stand in stark contrast to the level of enthusiasm displayed by hedge funds for the energy company during the first quarter of the year. At the end of the first quarter, a total of 21 of the hedge funds tracked by Insider Monkey held long positions in this stock, a surge of 75% from one quarter earlier. This massive increase in hedge fund interest is also mirrored in the burgeoning of their total holdings. The value of those holdings increased by 65.36% to $129.16 million by the end of March 2015, versus $78.11 million at the end of December 2014. This growth is even more amplified by the 5.5% decline in the price of the company’s shares during the first three months of the year. Nonetheless, shares dipped slightly in the second quarter even before the latest news, as the energy sector perhaps hasn’t rebounded to the extent money managers expected.

Let’s first take a step back and analyze how tracking hedge funds can help an everyday investor. Through our research, we discovered that a portfolio of the 15 most popular small-cap picks of hedge funds beat the S&P 500 Total Return Index by nearly a percentage point per month on average between 1999 and 2012. On the other hand, the most popular large-cap picks of hedge funds underperformed the same index by seven basis points per month during the same period. This is likely a surprise to many investors, who think of small-caps as risky, unpredictable stocks and put more faith in large-cap stocks. In forward tests since August 2012, these top small-cap stocks beat the market by an impressive 80 percentage points, returning over 135% (read the details here). Hence, a retail investor needs to isolate himself from the herd and take advantage of the best growth opportunities in the market by concentrating on small-cap stocks.

We also track insider trades to accurately deduce whether insiders of companies are also going long on their firms’ shares. Synergy Resources insiders did not make any purchases of shares in 2015. There were sales, however, the most recent being Director Robert W. Noffsinger III selling 100,000 shares total in two transactions at the start of last month.

Keeping this in mind, let’s take a look at the recent hedge fund action surrounding Synergy Resources Corp.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!